Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

Delayed Quote. Delayed  - 07/01 08:37:45 pm
87.1538 USD   +1.32%
01:09p VERTEX PHARMACE : Exploring the need for mutation-specific treatment..
06/18 VERTEX PHARMACE : (VRTX) Stock Rating Reaffirmed by Jefferies Group
06/17 VERTEX PHARMACE : Orkambi’s cost too high for benefit offered,..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Vertex Pharmaceuticals Inc
Discovers and develops novel, small molecule pharmaceuticals

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets.

It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis.

The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Number of employees : 1 950 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Pharmaceuticals580.42100%1,032100% +77.86%
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
United States361.0762.2%763.3273.9% +111.4%
Europe197.6134%219.6021.3% +11.13%
Other21.733.7%49.424.8% +127.45%
Managers
NameAgeSinceTitle
Jeff Leiden602009Chairman, President & Chief Executive Officer
Simon Bedson, MBA-2011SVP & GM-International Commercial Operations
Ian F. Smith492001CFO, EVP & Principal Financial Officer
Jeffrey A. Chodakewitz, MD602014Chief Medical Officer & Executive Vice President
David Matthew Altshuler MD, PhD512012Chief Scientific Officer & EVP-Global Research
Joshua S. Boger, PhD641989Director
Bruce I. Sachs, MBA561998Lead Independent Director
Elaine S. Ullian681997Lead Independent Director
Margaret G. McGlynn, MBA552011Independent Director
Terrence C. Kearney, MBA612011Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 247,349,864 245,630,140 99.3% 0 0.0% 99.3%
Shareholders
NameEquities%
T. Rowe Price Associates, Inc. 25,008,493 10.1%
Capital Research & Management Co. (World Investors) 21,598,162 8.73%
The Vanguard Group, Inc. 14,935,838 6.04%
Wellington Management Co. LLP 14,727,173 5.95%
Fidelity Management & Research Co. 14,484,166 5.86%
BlackRock Fund Advisors 12,190,582 4.93%
SSgA Funds Management, Inc. 9,790,008 3.96%
Columbia Management Investment Advisers LLC 8,505,426 3.44%
JPMorgan Investment Management, Inc. 8,212,383 3.32%
ClearBridge Investments LLC 7,623,324 3.08%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
AMGEN, INC.
GILEAD SCIENCES, ..
CELGENE CORPORATI..
REGENERON PHARMAC..
VERTEX PHARMACEUT..
ACTELION LTD
GENMAB A/S
MEDIVATION INC
HUALAN BIOLOGICAL..
TONGHUA DONGBAO P..
JUNO THERAPEUTICS..
NEUROCRINE BIOSCI..
TESARO INC
INTERCEPT PHARMAC..
PEPTIDREAM INC
BEIJING SL PHARMA..
CHINA BIOLOGIC PR..
KITE PHARMA INC
ANHUI ANKE BIOTEC..
BIOCON LTD
Sector Biotechnology & Medical Research
Vertex Pharmaceuticals Inc : Connections
SpiderCloud Wireless, Inc.
Institute of Medicine
The Alliance for Business Leadership
American Academy of Arts & Sciences
The Brigham & Women's Hospital, Inc.
The American Institute of Certified Public Accountants
Massachusetts Workforce Board Association
Institute of Chartered Accountants in England & Wales
Jibo, Inc.
The Financial Executives Institute
Abington Friends School
Massachusetts Mutual Life Insurance Co.
American Civil Liberties Union Foundation, Inc.
Infectious Diseases Society of America
Nantero, Inc.
The American Society for Clinical Pharmacology & Therapeutics
DataGravity, Inc.
Vertex Pharmaceuticals
iControl Networks, Inc.
New England Aquarium Corp.
Ravinia Festival Association
Massachusetts Institute of Technology
Clarus Ventures LLC
The Broad Institute, Inc.
Museum of Science
Whitehead Institute for Biomedical Research
WGBH Educational Foundation
American Society for Clinical Investigation
Massachusetts Life Sciences Center
Association of American Physicians
Accelerated Cure Project for Multiple Sclerosis
Alkeus Pharmaceuticals, Inc.
SimpliVity Corp.
The Boston Private Industry Council, Inc.
GreatCall, Inc.
Macp Organization
OneCloud Software, Inc.
Wesleyan University
Charles River Ventures, Inc.
Celebrity Series of Boston, Inc.
Biotechnology Industry Organization
The Hastings Center
Biolex Therapeutics, Inc.
Massachusetts Life Sciences Collaborative
Orphan Technologies Ltd.
New England Healthcare Institute
Harvard Medical School
Company contact information
50 avenue Northern
US-MA 02110 Boston, Massachusetts
États-Unis (les)

Phone : +1 617 444 6100
Fax : +1 617 444 6680
Internet : http://www.vpharm.com
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 / SP500
Stock Exchange Codes
- ISIN Code :  US92532F1003
- Bloomberg Code :  VRTX:US
- Reuters Code :  VRTX.O
- Datastream Code :  
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem